What Did This CEO Just Do with Personal Shares of Ophthotech Corp (NASDAQ: OPHT)?

By Carrie Williams

Today, the President & CEO of Ophthotech Corp (OPHTResearch Report), Glenn Sblendorio, sold shares of OPHT for $9,887.

See today’s analyst top recommended stocks >>

OPHT’s market cap is $59.2M and the company has a P/E ratio of 0.95. Currently, Ophthotech Corp has an average volume of 85.09K.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Ophthotech Corp. is a biopharmaceutical company which engages in discovering, developing, and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy.